Clinical Trials Directory

Trials / Completed

CompletedNCT00388895

Glivec in Ph Positive Lymphoblastic Leukemia

Positive Ph Acute Lymphoblastic Leucemia With Intensive Induction Chemotherapy and Glivec, Before and After the Hematopoetic Progenitor Transplant

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
35 (planned)
Sponsor
PETHEMA Foundation · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

% positive Ph LLA with RC alter the Glivec and induction chemotherapy treatment

Detailed description

Pilot phase II clinical trial, prospective, multicentric and opened

Conditions

Interventions

TypeNameDescription
DRUGchemotherapy
DRUGGlivec

Timeline

Start date
2002-06-01
Primary completion
2006-10-01
Completion
2007-10-01
First posted
2006-10-17
Last updated
2008-11-19

Locations

28 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT00388895. Inclusion in this directory is not an endorsement.